POWER COL-TRA PLLA éåœã®æé©ãªãã£ã©ãŒã®äœ¿çšæ³
ããª-L-ä¹³é
žãã¯ãŒã³ã«ãã©è¥è¿ãã®ããã®æåã®éžæè¢äœ¿ãæšãŠå»çæ©åšãã¯ãŒã³ã«ãã©é«å質ã®ãã£ã©ãŒããæ¢ãã§ãã?次ã®å©ç¹ãèæ
®ããŠãã ãããå®å
šæ§èªç¶ãé·æã¡ããç°¡åãªæ²»çæé å¯äœçšãªãçåè§£æ§é¢æ°ïŒåŸã
ã«2幎以äžç¶ã深局SMASå±€ã®ã³ã©ãŒã²ã³ãåºæ¿ããé¡ã®ããªã¥ãŒã ãèªç¶ã«ç¶æããŸããKFDAã®æ¿èªãåãã補é ããã³è²©å£²ç±³åœFDAæ¿èªããã³åœå
å€ç¹èš±ååŸæžã¿çŽ æãã¯ãŒã³ã«ãã©ã³ã¢ãã¯ãããžãŒã®ç޹ä»:- ç¡æº¶å€ã§ã®é«ååç²åè£œé æè¡- çåè§£æ§ããªããŒç²åã®éæº¶åªæè¡ (NST)Sculptraãšã®æ¯èŒã®å©ç¹:- POWER COL-TRA ã®çç¶åŸ®ç²åã¯ãSculptra ã®éæ¶è³ªåœ¢ç¶ãšæ¯èŒããŠãç®èå±€éã«åªããäœç©çæãæäŸããŸããçµæžç/瀟äŒç圱é¿:ã»ææ©æº¶å€ã䜿çšããªããããã³ã¹ãåæžãšçç£æ§ã®åäžãå³ããŸãã- åŽåç°å¢ã®é©æ°çæ¹å- ç°å¢ã«é
æ
®ãã補åã®çç£ãšäŒæ¥ã€ã¡ãŒãžã®åäžã»ææ©æº¶å€èŠå¶ã«å¯Ÿå¿ããæµ·å€äºæ¥ã®æ¡å€§ãPOWER COL-TRA ã¯ãè¥è¿ãã®ããã®é·ææç¶çã§å®å
šãã€å¹æçãªãœãªã¥ãŒã·ã§ã³ãæäŸããŸããåœç€Ÿã®é«åºŠãªé溶å€è£œé æè¡ã«ãããã客æ§ã«æé«ã®çµæãä¿èšŒããŸããæ²»çæé ã¯ç°¡åã§ã埮ç²åé
åã«ããåªããã³ã©ãŒã²ã³çæå¹æãåŸãããŸããã客æ§ã®çŸçããŒãºã«å¿ããåªããéžæè¢ã§ãã POWER COL-TRA ããéžã³ãã ããã詳现ã«ã€ããŠããã«è©±ãåããçžäºã®æåã«åããŠååãç¶ç¶ã§ããããšã楜ãã¿ã«ããŠããŸãã
PDRN ãšã¯äœã§ãã? ãªãããã»ã©äººæ°ãââããã®ã§ãã?
èŠçŽãããšãéåœã®æå人ã¯çŸå®¹åŠçœ®ã«ããŸããŸãªãã©ã³ãã®ãããã¯ã¹ã䜿çšããŠããããšãç¥ãããŠããŸãã人æ°ã®éåœãã©ã³ãã«ã¯ãMedytoxãHugelãDaewoong Pharmaceuticals ãªã©ããããMedytox ã¯äž»èŠã¡ãŒã«ãŒã® 1 ã€ã§ãã Nabota ã¯ãç®èæ²»çã«äœ¿çšãããéåœã®ãããã¯ã¹ ãã©ã³ããšããŠãåºãç¥ãããŠãããDysport ã Xeomin ãªã©ã®ä»ã®ãã©ã³ããšåæ§ã«ãçèã®åçž®ãé²ããé¡ã®ã©ã€ã³ãããã軜æžãã广ããããŸãããã ããå®å
šã§å¹æçãªçµæãåŸãã«ã¯ãçµéšãšè³æ Œã®ããæœè¡è
ãéžã¶ããšãäžå¯æ¬ ã§ãã
é¡ãåã¿ãããããšã®å¯äœçšã¯äœã§ããããããŠãªããããªãã¹ããã·ã³ã¯é¡ã®åã¿ããã«å¹æçãªã®ã§ããïŒ
é¡ã®åã¿ããã®å¯äœçšã¯äœã§ããïŒ
é¡ã®åã¿ããïŒæ¯ãããïŒã¯ãçã¿ã䌎ãé çãæ¯ã®æå·ãåŒãèµ·ããããšããããŸããåã¿ããã®æ²»çæ³ã«ã¯ãçç¶ãåãããããã®ãã€ãªãã£ãŒãããã¯ããªã©ã¯ãŒãŒã·ã§ã³ãšã¯ãµãµã€ãºããããŸãã
ãããªãã¹ããã·ã³ã¯ãããæžãããè¥ã
ããé¡ã®å€èгãåçããããšã§æãããç¥ãããŠããŸãããæ¯ããããå«ãããã€ãã®çç¶ã®æ²»çã«ã䜿ãããããšããããŸãããã®æ²»çæ³ã¯ãæ¿èªããã䜿çšãå€ã®ãã®ã§ãããæ²»çãå§ããåã«ä¿éºäŒç€Ÿã«ç¢ºèªããŠãã ãããããã¯ãªãã©ãã«æ²»çãããã³ã«ã®äžç°ãšããŠä¿éºäŒç€Ÿãžã®çžè«ãå¿
èŠã«ãªãå ŽåããããŸãã
1. é ç
ç¡ç äžã®æ¯ãããã¯æ¿ããé çãåŒãèµ·ããããšããããããå€éã«èµ·ããå Žåã¯ããã«æ²»çãåããããšãéèŠã§ããå
åã«ã¯ãç®èŠãããšãã®é¡ã®çã¿ãããã°ããæ¯ã®ç¥èŠéæãæ¯ã®ã²ã³å²ãããããã¿ã®é çïŒç¹ã«ããããå§ãŸããã®ïŒãé¡é¢ãé çãå«ãŸããŸããããã¯æ¯ããããšããŠãç¥ãããè³ã®çã¿ãé¡é¢ç¯ã®æå·ãªã©TMJã®åé¡ãåŒãèµ·ããåã«æ²»çããå¿
èŠããããŸãããããã£ãŠããã®åé¡ã¯æ©æã«æ²»çå¯èœã§ãïŒ
ãããªãã¹ããã·ã³ã¯ãåã¿ããã«é¢äžããçèãã¿ãŒã²ããã«ãã驿°çãªéäŸµè¥²çæ²»çæ³ã§ãããããªãã¹ããã·ã³ã¯åçž®ãåŒãèµ·ããã¢ã»ãã«ã³ãªã³ã®æŸåºãæå¶ããŸããå¬çã«æ³šå°ããããšãçèã®åçž®ãæ¢ããé¡ã®çã¿ãTMJéå®³ãæ¯ããããé¡ã®ããã¯ãæ¯ãããã«é¢é£ããçé çãªã©ã®çç¶ãç·©åããŸãã
æ¯ãããã¯ç¡ç é害ãäžå®ãã¹ãã¬ã¹ãè¬ç©ãæ é€äžè¶³ã«ãã£ãŠåŒãèµ·ããããããšããããŸããæãäžè¬çã«ã¯åäŸãéå°å¹Žã«èŠãããŸããã誰ã§ãã©ã®å¹Žéœ¢ã§ã圱é¿ãåããå¯èœæ§ããããŸããæ¯ãããã®ãªã¹ã¯èŠå ã«ã¯å€§é飲é
ãå«ç
ãã¬ã ã®äœ¿çšããããŠæ»æçãŸãã¯ç«¶äºçãªæ§æ Œã¿ã€ããå«ãŸãããããã¯çç¶ãæªåãããããšããããŸãã
é¡ã®é床ãªåã¿ãããæ¯ãããã¯ãæ¿ããé çãæ¯ã®æå·ãTMJçç¶ãè³ã®çã¿ãåŒãèµ·ããããšããããŸãããã¥ãŒãšãŒã¯åžã®ãã·ã§ã«ã»ã°ãªãŒã³å»åž«ã¯ãå¬çãžã®ãããªãã¹ããã·ã³æ³šå°ã«ããç·©åãæäŸã§ããŸãã圌女ã¯ãã®æ²»çæ³ãçšããŠæ¯ããããšTMJã®äž¡æ¹ãæ²»çããå°éå®¶ã§ããéåžžãçžè«æã«é¡ã®äž¡åŽã«15ïœ25åäœã泚å°ããæ¯ãããã®çç¶ãåãããŸãã广ã¯äžè¬çã«3ã¶ææç¶ããŸãããå¿
èŠã«å¿ããŠç¹°ãè¿ãæ²»çãå¯èœã§ããèå³ãããæ¹ã¯ä»ããåœé¢ã«ãé£çµ¡ãã ããïŒ
2. TMJ
é¡ã匷ãåã¿ãããããšã§èŠããå€ãã®äººã
ã¯ãé¡é¢ç¯ïŒTMJïŒã®çã¿ãäžå¿«æã«æ©ãŸãããŠããŸããåã¿ããã¯TMJçå矀ãåŒãèµ·ãããé çãé ãè³ã®åšãã®çã¿ãå£ãéãããšãã®ã¯ãªãã¯é³ãé£ã¹ç©ãåãã®ãå°é£ã«ãªããé¡ã®ããã°ããªã©ã®çç¶ããããããŸãã
TMJïŒé¡é¢ç¯ïŒã¯é¡ã®äž¡åŽã«ãã2ã€ã®é¢ç¯ã§ãé è骚ãšé¡éªšãã€ãªããé¡ãäžäžå·Šå³ã«åãããå£ãééãã圹å²ãæãããŸãããããã®éšäœãåããã®ãå©ããé éšåšèŸºã®çèã¯TMJã«æ¥ç¶ãããŠããããããããã®éšäœã®ã±ã¢ãããã«éèŠã«ãªããŸãã
TMJã®äž»ãªæ²»çæ³ã®äžã€ã¯çåŠçæ³ã§ããããã€ãªãã£ãŒãããã¯ãè¶
鳿³¢æ²»çãã¹ãã¬ãããªã©ã®éåãå«ãŸããŸãããããã®æ¹æ³ã¯é¡ã®éªšã®å¯åæ§ãé«ããçç¶ã軜æžããããšãç®çãšããŠããŸãããã®ä»ã®æ²»çæ³ãšããŠã¯ãæççè¬ãçåŒç·©è¬ãæçšããŠå€éã®ç¡ç ãæ¹åããããšããããŸãã
ãããã®æ²»çæ³ã¯TMJããã³é¡ã®çã¿ã®ç·©åã«ããçšåºŠå¹æããããããããŸããããçç¶ã®è»œæžã«ã¯éçããããŸããããã«ãçåäœäžãèŠåé害ãåŒåžå°é£ãç¡ç é害ãªã©ã®ããæ·±å»ãªå¯äœçšãåŒãèµ·ããå¯èœæ§ããããŸãããããªãã¹ããã·ã³ã¯ãTMJãé¡ã®çã¿ãç·©åããã®ã«æåããŠããããäžã€ã®æå¹ãªéžæè¢ãããããŸããã
ãããªãã¹ããã·ã³ã¯ãåŸæ¥ã®æ¯ç§æ²»çãæ¯ã®çã¿ãç¥èŠéæã®ç·©åã«çŠç¹ãåœãŠãã®ã«å¯ŸããTMJããã³é¡åšèŸºã®çèãçŽæ¥æšçãšãããããé¡ã®åã¿ããã®æ²»çã«å¹æçã§ããããã«ãæ¯ãåã¿ããããæ¯ããããããçèãç¹ã«çãæã¡ããŸãã
ãã®æ²»çã®å©ç¹ã¯å³å¹æ§ã«ãããéåžžãæ³šå°åŸæ°ã¶æä»¥å
ã«TMJããã³é¡ã®çã¿ã倧å¹
ã«æžå°ãããã®åŸã¯ããããç¶æããããã®ã¡ã³ããã³ã¹æ²»çãè¡ãããŸãã
3. é¡ã®çã¿
é¡é¢ç¯ïŒäžè¬ã«é¡é¢ç¯çãŸãã¯TMJãšåŒã°ããïŒã¯ãé ã®äž¡åŽãã€ãªããé¡ãååŸã«åããããšãå¯èœã«ããŸããæ¯ãåã¿ããããæ¯ãããããããšããã®åããå¶åŸ¡ããçèãç·åŒµããé¢ç¯ã«å§åãããããŸãããã®çµæãè³ãé¡ããããã¿ã®åšèŸºã«çã¿ãå§çãçããããšããããéãçã¿ããéã黿°çãªçã¿ãŸã§æ§ã
ãªçç¶ãé¢ç¯åšèŸºã«çŸããŸããããã«ãããæ¯ãæ¬ ãããå²ãããæãããããããšãããããããã®æå·ããå®å
šã«å埩ããããã«ã¯å°éçãªæ¯ç§æ²»çãå¿
èŠãšãªããŸãã
ããããããšã§ãããé¡ã®åã¿ãããæ¯ãããã¯ãã¹ãã¬ã¹ãäžå®ãªã©ã®ææ
çãªåé¡ãåå ã§èµ·ããããšãããããã®çµæãé¡ã宿çã«ç·åŒµãããã©ãã·ãºã ã®çç¶ãåŒãèµ·ãããŸãããã®ä»ã®åå ãšããŠã¯ãæç²Ÿç¥ç
è¬ãéžæçã»ãããã³ååã蟌ã¿é»å®³è¬ã®ãããªè¬å€ãããããããã¯è³ãé¡ã®é¢ç¯ãçèã«ä¿¡å·ãéãæ¹æ³ãå€åãããã»ããé塿§ç¡ç æç¡åŒåžçå矀ã®ãããªç¡ç é害ããã®è¡åãšé¢é£ããŠããŸãã
é¡ã®é£ããã°ããæ¯ããããåŒãèµ·ããè¬ã®åé¿ã¯å€ãã®æ£è
ã«ãšã£ãŠå°é£ã§ããããããã®è¡åã«äŒŽãçã¿ã管çãã广çãªè§£æ±ºçã¯ååšããŸãããããªãã¹ããã·ã³æ³šå°ã¯ãå¬çã®ç·åŒµãåŒãèµ·ããã¢ã»ãã«ã³ãªã³ã®æŸåºããããã¯ããŠçèã®åçž®ãæå¶ããããšã§ãé¡ã®çèã®ç·åŒµãåãããçã¿ã¯ãããã®ã®ç·©ãã é¡ãæ¯ããããããªããªãããã«äžéšã®ç·©åãæäŸãããããããŸããïŒ
ãããªãã¹ããã·ã³ã¯ãèšç·Žãåãèªå®ãããçŸå®¹ç®èç§å»ã«ãã£ãŠæäžãããå Žåãé¡ã®é£ããã°ããæ¯ãããã«å¯ŸããŠå¹æçãã€å®å
šãªæ²»çæ³ãšãªãåŸãŸããããããç¡è³æ Œã®æœè¡è
ã«ãã£ãŠæäžããããšããããªãã¹ããã·ã³ãäœå
šäœã«åºãããå
šèº«ã®çåäœäžãåŒåžãå¥äžã®å°é£ãçºè©±ãèŠèŠã®åé¡ãããã«ã¯å€±æãèšèªé害ãåŒãèµ·ãããªã¹ã¯ãé«ãŸããŸãã
4. æ¯ããã
ã¹ãã¬ã¹ãäžå®ã¯ãã°ãã°é¡ã®ç·åŒµã®æ ¹æ¬åå ã§ãããé¡ã®é£ããã°ãã¯äžå¿«ãªç¶æ³ã«å¯Ÿããç¡æèã®åå¿ãšããŠããèŠãããŸããæ®å¿µãªãããæŸçœ®ãããšæ
¢æ§çãªé¡ã®é£ããã°ãã¯é¡é¢ç¯ã«åœ±é¿ãåãŒãããæ·±å»ãªé害ãåŒãèµ·ããå¯èœæ§ãããããã®çç¶ã«ã¯é¡ãé¡ã®çã¿ãè³ãç®ã®åšãã®å§çãé£ã¹ç©ãé©åã«åãããšã®å°é£ãå£ãéãéãããéã®ã¯ãªãã¯é³ããããé³ãªã©ãå«ãŸããŸãã
æ¯ãããïŒããªãã·ãºã ïŒã¯ãé¡ã®é£ããã°ãã®ããäžã€ã®å¯äœçšã§ãããæ¯ãããæžã£ãããå¹³ãã«ãªã£ãããæãããããããšããããããŸããããã«ããã®è¡åã¯é çãè³çãé¡ã®çã¿ãåè§ãèŠããé¡ã®ã©ã€ã³ãåŒãèµ·ããããšããããé©åã«æ²»çãããªãå Žåã¯èŽåœçãªç Žå·é¢šææçã«è³ãããšããããŸãã
æ¯ç§å»ã¯ãã¹ããªã³ãïŒäžãŸãã¯äžã®æ¯ã«è£
çããã¢ã¯ãªã«è£œã®ã¬ãŒãïŒãªã©ãé¡ã®é£ããã°ãã«å¯ŸåŠããããŸããŸãªæ²»çãæäŸããŠããŸãããŸããæ£è
ãäžè¬å»ããªã©ã¯ãŒãŒã·ã§ã³ã»ã©ãã¹ããç¡ç å°éå»ã«ç޹ä»ããé¡ã®é£ããã°ãã«å¯äžãã粟ç¥çå¥åº·ãç¡ç ã®åé¡ãæ¹åããããšããããŸãããããã¯ãã¹ãŠãå¯äžèŠå ã«å¯ŸåŠããã®ã«åœ¹ç«ã€å¯èœæ§ããããŸãã
ãããªãã¹ããã·ã³æ³šå°ã¯ãé¡ã®é£ããã°ããé¢é£çç¶ã«å¯ŸåŠããæè¯ã®æ¹æ³ã®äžã€ã§ãããå®å
šã§å¹æçãªç·©åãæäŸããŸãã1970幎代ã«çèã麻çºãããŠãããæžããããã«åããŠäœ¿çšãããç¥çµæ¯æ§ã®ãããªãã¹ããã·ã³ãå°éå«ããããªãã¹ããã·ã³ã¯ãå¬çã®åçž®ãåŒãèµ·ããååŠç©è³ªã®æŸåºããããã¯ããé¡ã®ç·åŒµãåãããããšã§æ¯ãããã®æ²»çã«å®å
šãã€å¹æçãªæ²»çæ³ã§ãã
ãããªãã¹ããã·ã³æ²»çã¯éåžžã«åå¥åãããŠãããããé©åãªèšç·Žãåããçµéšè±å¯ãªæœè¡è
ãéžã¶ããšãäžå¯æ¬ ã§ããããã§ãªããã°ã誀ã£ãæœè¡ã«ããäœã®ä»ã®éšåã®çåäœäžãå¥äžå°é£ãåŒåžé害ãçããå¯èœæ§ããããŸããããTMJã«é¢é£ããé¡ã®é£ããã°ãã®çç¶ã«å¯ŸããŠãããªãã¹ããã·ã³ã詊ããŠã¿ããå Žåã¯ãããã«åœããŒã ã«ãé£çµ¡ããã ããäºçŽããåããã ããïŒTMJã«ããçç¶ãåãããå®å¿ããŠããã ãããããæäŒãã§ããããšã楜ãã¿ã«ããŠããŸãïŒ
ãã¢ã«ãã³ãã³ãã£ã©ãŒãšã¯äœã§ãã?ãã€ã¯ãããŒããªã³ã°ã泚å°å¯èœãªãã£ã©ãŒãšã©ãéãã®ã§ãã?
ãã¢ã«ãã³ãã³ãã£ã©ãŒ ãã¢ã«ãã³ãã³ã¯ãéã䜿ããã«ç°¡åãã€å®å
šã«ãã¢ã«ãã³é
žãæäžããæ¹æ³ã§ããå§åã§äœåãããããã¯ãç®èã®è¡šé¢ã®äžã«å®å
šã«æ³šå
¥ããã®ã«ååãªåãçã¿åºããŸãã ãã®ããªãŒãã¡ã³ãã¯ãéãæããã客æ§ããŸãã¯åŸæ¥ã®ãã£ã©ãŒè£œåã®é泚å°ãåããããªãã客æ§ã«æé©ã§ããããã«ã䟵襲æ§ãäœãã§ãã ãã¢ã«ãã³ãã³ãã£ã©ãŒãšã¯äœã§ãã? ãã¢ã«ãã³é
žãã³ãã£ã©ãŒã¯ãã»ãããç·ãããªãªãããã©ã€ã³ãªã©ã®é¡ã®çްãç·ãæ»ããã«ããæãããããããã«èšèšãããéã®ãªã泚å°å€ã§ãããããã¯ãåšå²ã®çµç¹ãå·ã€ããããšãªããã¢ã«ãã³é
žãã£ã©ãŒãåäžãªæµãã§ç®èã«æµžéãããã®ã«ååãªå§åãå ããããšã§æ©èœããŸããæ²»çã¯éåžžãçã¿ã䌎ããã«è¿
éã«è¡ãããŸãããã®åŸè
«ãããããçºèµ€ãçŸããããšããããŸãããçç¶ã¯éåžžæ°æé以å
ã«æ²»ãŸããŸãã ãã¢ã«ãã³é
žãã³ã®äœ¿çšã¯ããã®æé ã«éã䜿çšããªããããåŸæ¥ã®å泚å°ãããçã¿ãã¯ããã«å°ãªããšå€ãã®ã¯ã©ã€ã¢ã³ããå ±åããŠããŸãããã ããããã¯äžæçãªè§£æ±ºçãšããŠã®ã¿èæ
®ãããã¹ãã§ãããæé©ãªçµæãç¶æããã«ã¯æ°ãæããšã«ä¿®æ£ãå¿
èŠã«ãªãå Žåãããããšã«æ³šæããŠãã ããã åžå Žã«ã¯ããŸããŸãªãã©ã³ãã®ãã¢ã«ãã³é
žãã³ã販売ãããŠããããã®å質ã¯å€§ããç°ãªãå ŽåããããŸãã FDA ã®æ¿èªãåããä¿¡é Œã§ããäŒæ¥ã«ãã£ãŠè£œé ãããŠãããã®ãããã°ãããã§ãªããã®ããããŸããå®¶åºçšã¢ãã«ã¯èª€äœåãèµ·ãããé广çãŸãã¯å±éºãªçµæã«ã€ãªããå¯èœæ§ãããããŸãã ãã¢ã«ãã³é
žãã³ã¯ãã«ã«ã·ãŠã ããããã·ã«ã¢ãã¿ã€ã (CaHa) ã»ã©é·æçãªè§£æ±ºçã§ã¯ãããŸããããã¢ã«ãã³é
žã¯ãèªç¶ã«åè§£ãããŠäœã«åžåããããŸã§ãããã 6 ïœ 8 é±éããæç¶ããŸããã ãã¢ã«ãã³é
žãã³ã«ã¯ããã£ã©ãŒãäžé©åãªé åã«é
眮ãããªã¹ã¯ã䌎ããŸããããã«ãããçæ³çãšã¯èšããªãçµæãåŸãããå¯èœæ§ããããããã«ã¯è¡ç®¡ã®è©°ãŸããªã©ã®å䜵çãçºçããŠç®ãžã®é
žçŽ ã®æµããæžå°ããæ¥µç«¯ãªå Žåã«ã¯äžæçãªå€±æãåŒãèµ·ããå¯èœæ§ããããŸãã ãã¢ã«ãã³é
žãã³ã¯ä»ã®æ³šå°ã®ããã«ã³ã©ãŒã²ã³ã®çæãåºæ¿ãããè¥ããå埩ããã³ã©ãŒã²ã³ã®çæãšããéèŠãªåŽé¢ãæ¬ ããŠããããããã€ã¯ãããŒããªã³ã°ãªã©ã®æ²»çæ³ãããç®èã®å¥åº·ãžã®æçæ§ãäœããªããŸããããã§ãããããã¯è¿
éãã€é·æçãªçµæãæäŸãããªãããã£ã©ãŒãªã©ã®åŸæ¥ã®ãã£ã©ãŒã®è¿
éãªè§£æ±ºçãæ¢ããŠããå Žåã«ä»£æ¿ãªãã·ã§ã³ãæäŸããå¯èœæ§ããããŸãã ãã¢ã«ãã³ãã³ãã£ã©ãŒã¯ãã€ã¯ãããŒãã«ã泚å°å¯èœãªãã£ã©ãŒãšã©ãéãã®ã§ãã? ãã¢ã«ãã³ãã³ãã£ã©ãŒã¯ãéã®ä»£ããã«ç©ºæ°å§ã䜿çšããŠæ³šå°ãè¡ãç¹ã§åŸæ¥ã®æ³šå°ãšã¯ç°ãªããå ããå§åãå§åãå¶åŸ¡ãããã©ã³ãžã£ãŒããããŸããããããã¯ããã«é£ãããªããçµæãäºæž¬ãã«ãããªããŸããããã«ããããã¯é¡ã®çç®ä¹³é å±€ã«ã®ã¿å°éãããã倧ããªå€åãå ããããšãã§ããŸããã ãããã®ãã³ã«äœ¿çšãããŠãããã¢ã«ãã³é
žã¯äœå
ã§èªç¶ã«çæãããããããã®æ©èœã¯äœå
ã§çæããããã¢ã«ãã³é
žãåæ ããŠããŸãããã¢ã«ãã³é
žã¯æ°ŽååãåŒãä»ããç®è现èã«æœ€ããäžããèŠãç®ããããµã£ãããšè±ãã«ããããšãã§ããŸããããã«ããã®æ¶æ©ç¹æ§ã¯ãäœå
ã®é
µçŽ ã«ããåè§£ãé²ãã®ã«åœ¹ç«ã¡ãŸãããã ãã人éã®äœå
ã§çæããããã®ç©è³ªã®å¯¿åœã¯ããã®ç©è³ªã§äœããããã£ã©ãŒãæ°ãæãå Žåã«ãã£ãŠã¯æ°å¹Žãæ¶æ©ã§ããã®ã«æ¯ã¹ãŠæ¯èŒççãã§ãã ãã£ã©ãŒã®åãåãã«é¢ããŠã¯ãè³æ Œã®ããçŸå®¹æœè¡è
ã®ã¿ãæœè¡ãè¡ãå¿
èŠããããŸãã圌ãã®ã¹ãã«ãšç¥èã¯å®å
šã§å¹æçãªãã£ã©ãŒæ²»çãä¿èšŒããŸããæ³šå°ã®å質ã«é¢ãã FDA åºæºãæºãããŠããªããã¢ã«ãã³ ãã³ãªã©ã®æªæ¿èªã®åšå
·ã䜿çšããŠèªå®
ã§ãã£ã©ãŒã詊ã¿ãããšã¯æ±ºããŠæšå¥šãããŸããã ãã¢ã«ãã³ãã³ã䜿çšããå ŽåãææãæãŸãããªãå¯äœçšãé²ãããã«ãå®ãã¹ãéèŠãªã«ãŒã«ãããã€ããããŸããå¿
ãç¡èç°å¢ã§äœ¿çšããæ±æã«å¯ŸããŠããããäºé²æªçœ®ãè¬ããŠãã ãããåžžã«å
å¡«æžã¿ã®ã¢ã³ãã«ã䜿çšããŠãã ãããèªåã®ãã¢ã«ãã³é
žãããã€ã¹ã«çŽæ¥è¿œå ããªãã§ãã ããã ãã¢ã«ãã³ãã£ã©ãŒã¯åã匷調ããç®çã®ã¿ã«äœ¿çšããããšããåŸãã¹ãéèŠãªã«ãŒã«ã§ããããšã«æ³šæããŠãã ããããã®ä»ã®äœ¿çšã¯å䜵çãåŒãèµ·ããå¯èœæ§ããããããå»çæäŸè
ã®äºåã®çžè«ãšæ¿èªãªãã«äœ¿çšããªãã§ãã ãããããã«ããã®åœ¢åŒã®æ²»çæ³ã¯ããã€ã¯ãããŒãã«ã泚å°å¯èœãªãã£ã©ãŒã«ä»£ãããã®ã§ã¯ãããŸãããã©ã¡ããããŠã³ã¿ã€ã ãå¿
èŠãšããããããæ»ããã«ããŠå¹Žéœ¢ãæããããªãèŠãç®ã«ããã®ã«åœ¹ç«ã¡ãŸãããããè¥è¿ãã®æè¯ã®æ¹æ³ã§ãã ãã¢ã«ãã³ãã³ãã£ã©ãŒã®å©ç¹ã¯äœã§ãã? ãã¢ã«ãã³é
žãã³ãã£ã©ãŒã¯ãããªã¥ãŒã ã远å ããå°ããããããä¿®æ£ããèã®å
šäœçãªå€èŠ³ãæ¹åããããã®å¹æçã§é䟵襲çãªãœãªã¥ãŒã·ã§ã³ãæäŸããŸãããã¢ã«ãã³é
žãã³ã¯ãã³ã¹ããåæžãããå¯äœçšããªããããç®èå
å¡«å€ããããã¯ã¹æ³šå°ã®çæ³çãªä»£æ¿åã§ãã ãã¢ã«ãã³ãã³ã¯ãéã§ã¯ãªã空æ°å§ã䜿çšããŠãã¢ã«ãã³é
žãç®èã«æ³šå
¥ãããããä»ã®ãã£ã©ãŒæ³šå°ãšã¯ç°ãªããŸããå§åã¯ç¥çµãè¡ç®¡ã«åœ±é¿ãäžããããšãªã衚ç®ã®ä¹³é å±€ã«èªå°ããããããææèã®æ£è
ãæ²»çããéã«å®å
šã«äœ¿çšã§ããããã€ã¹ãšãªããŸãã...
éåœã®ãã£ã©ãŒã®å€æ®µã¯ãããã§ãã?ãããŠã©ããæè¯ã®ãã£ã©ãŒã§ãã?
éåœã¯çŸå®¹æŽåœ¢ãšçŸå®¹æ³šå°ç£æ¥ã§æåã§ããé«åºŠãªãã¢ã«ãã³é
žããŒããã£ã©ãŒè£œé æè¡ãæããŠãããäŸ¡æ Œç«¶äºåã®ããé«å質ã®HAãã£ã©ãŒãçç£ããŠããŸãã Yvoire ãš Elravie ã¯ã泚å°ããã»ã¹ã®å®å®æ§ãé«ããã·ãªã³ãžèšèšã§ç¥ããã KFDA æ¿èªã®ãã£ã©ãŒ ãã©ã³ãã§ãã Teosyal ã¯ãã¢ã¬ã«ã®ãŒåå¿ãæããããã«ã¿ã³ãã¯è³ªäžçŽç©ãåæžãã人æ°ã®ãã£ã©ãŒ ãã©ã³ãã§ããæéãã§ã€ã·ã£ã«ãã£ã©ãŒã®è³Œå
¥ãèšç»ããŠããå Žåã¯ãé©åãªãã©ã³ããšæè¡ãéžæããããšãéèŠã§ãããã®ããªãŒãã¡ã³ãã¯ãèªç¶ãªèŠãç®ã®ãã§ã€ã¹ãªãããå®çŸããèãè¥è¿ãããã®ã«åœ¹ç«ã¡ãŸããã»ãããç·ãåãé€ããåãçŸãããã錻ã®åœ¢ãæ¹åããããã«ã䜿çšã§ããŸãããããã®ç®èå
å¡«å€ã¯ã现ãéã®æ³šå°åšã䜿çšããŠæšçé åã«æ³šå
¥ãããŸããæé ã¯è¿
éã§çã¿ã¯ãããŸããã ããŸããŸãªçš®é¡ã®ãã£ã©ãŒãå©çšå¯èœã§ãããæãåªããŠããã®ã¯ãæç¶æéãé·ããèªç¶ãªä»äžããããããããã£ã©ãŒã§ããæãäžè¬çãªãã£ã©ãŒã«ã¯ããã¢ã«ãã³é
žãšããª-L-ä¹³é
ž (PLLA) ãå«ãŸããŸãããããã®ãã£ã©ãŒã¯æç¶æ§ããããã³ã©ãŒã²ã³ã®æé·ãä¿é²ããèãæ»ããã§ããªããã«ããŸããçŸå®¹å¹æãé«ããããã«ãå®å
šã«äœ¿çšã§ããŸãããã§ã€ã¹ãã£ã©ãŒãéžã¶ãšãã¯ãäºç®ãšæãçµæãèæ
®ããããšãéèŠã§ããããšãã°ããªãããã£ã©ãŒã®äŸ¡æ Œã¯éåžž 2,000 ãã«ãã 4,000 ãã«ã§ããéžæããæè¡ã«å¿ããŠãçµæã¯æå€§ 5 幎éæç¶ããŸãããã¢ã«ãã³é
žç®èå
å¡«å€ã«ã¯ãã¢ã¡ãªã«ãéåœã®ãã©ã³ããªã©ãããã€ãã®éžæè¢ããããŸããã¢ã¡ãªã«è£œåã¯äžè¬çã«é«äŸ¡ã§ãããéåœè£œåã¯ããæé ãªäŸ¡æ Œã§ããäŸ¡æ Œã®éãã¯ãéåœè£œãã£ã©ãŒãã¯ãªããã¯ã§ããåºã䜿çšãããŠããããã®çµæãäŸ¡æ Œãå®ããªã£ãŠããããã§ãã éåœã§æã人æ°ã®ãããã¢ã«ãã³é
žãã£ã©ãŒãã©ã³ãã¯Revolaxã§ãçºå£²ãããŠ6幎ã«ãªããŸãããã®ãã©ã³ãã¯ããã®èä¹
æ§ãšé«ãç²åºŠã®ãããã§ãçŸå®¹ã«äººæ°ã®ãã©ã³ããšãªã£ãŠããŸãããã®ãã©ã³ãã¯FDAããã³KFDAã®æ¿èªãåããŠãããå®å
šã«äœ¿çšã§ããŸããå瀟ã§ã¯ç¡æçžè«ãè¡ã£ãŠããã®ã§ãæç¶ãã«æ
£ããŠããªã人ã§ãå®å¿ã§ãããã¢ã«ãã³é
žãã£ã©ãŒã®ãã 1 ã€ã®éžæè¢ã¯ãããŸããŸãªåæ°žä¹
ãã£ã©ãŒãæäŸãã Remedium ã§ãããã®äŒç€Ÿã¯ããã¢ã«ãã³é
žéãç¹èš±ååŸæžã¿ã®åŸ®ç²åã§æ¶æ©ããããšã«ããé«ç²åºŠã®ã²ã«ãäœæããããšãå°éãšããŠããŸããåŸããã補åã¯èä¹
æ§ããããæåœ¢æ§ãåªããŠããŸããéåœã§äººæ°ã®ããä»ã®ãã¢ã«ãã³é
žãã£ã©ãŒ ãã©ã³ãã«ã¯ãã€ãã¯ãŒã«ããã¥ãŒã©ãã¹ããšã©ãŽã£ãªã©ããããŸãããããã®ãã§ã€ã¹ãã£ã©ãŒã¯ãèã«ãµã£ããæãäžããããªã¥ãŒã ãããããããã«èšèšãããŠããŸããéåžžãé ¬ããããé¡ã®ã©ã€ã³ã®é åã«äœ¿çšããããšããå§ãããŸããæšå¥šäºé
éåœã¯ããªãããã£ã©ãŒãã¯ãããšããå€ãã®çŸå®¹å¹æã®ããæ²»çæ³ã§ç¥ãããŠããŸãããããã¯åãçŸããããããè±ãã§é
åçãªãã®ã«ããã®ã«æé©ã§ãããããã¯ãããæ»ããã«ããç·ãæžããã®ã«ã广çã§ããããã¯æ°åã§å®äºããç°¡åãªæ²»çæ³ã§ã蚺å¯å®€ã§ããã«è¡ãããšãã§ããŸããæœè¡åŸã¯å€å°ã®è
«ããåºãå ŽåããããŸãããããã«ä»äºãæ¥åžžç掻ã«åŸ©åž°ããŠããã ããŸããåžå Žã«ã¯ããã€ãã®ç°ãªãçš®é¡ã®ãã¢ã«ãã³é
žãã§ã€ã¹ãã£ã©ãŒãããããããã¯ãã¹ãŠç°ãªãåããããŸããåæ°žä¹
çãªãã®ããããŸãã®ã§ãæ°å¹Žé䜿çšã§ãããã®ããããŸãããããã¯ã幎霢ãšãšãã«å€±ãããã³ã©ãŒã²ã³ã埩掻ãããã®ã«ãæé©ã§ããæã人æ°ã®ãããã¢ã«ãã³é
žãã£ã©ãŒã«ã¯ãJuvedermãRestylaneãRevolax ãªã©ããããŸãããããã¯ãã¹ãŠãããè¥ã
ããèŠããããæ£è
ã«ãšã£ãŠã¯è¯ãéžæã§ããã4ïœ6é±éããšã®ãã©ããŒã¢ããæ²»çãå¿
èŠã§ãã ãã 1...
ããããã£ã©ãŒã¯ãããã®ããŒã¿ã軜æžããŸã
è¡é¢ç¯ã®ããŒã¿ãç®ç«ããªããããå Žåã¯ãããã€ãã®ãªãã·ã§ã³ããããŸããæè¡ãåããããšããè¡é¢ç¯ãã£ã©ãŒãªã©ã®éå€ç§çä»£æ¿ææ®µã«é Œãããšãã§ããŸãã å¢å€§æ²»çãšããŠãç¥ãããããããã£ã©ãŒã¯ããããã®èŒªéãæ¹åããããåŒãç· ãŸã£ãå€èгãäžããããã«èšèšãããŠããŸããã³ã«ãã³ã¹ããã€ããå€è¡å°æ¿è¡æŒ¿ (PRP)ãèèªç§»æ€ãªã©ãããã€ãã®æè¡ããããŸãã ã³ã«ãã³ã¹ããã€ã ã³ã«ãã³ã¹ããã€ãã¯ãããŸããŸãªçç¶ã®æ²»çã«äœ¿çšãããäººå·¥ã®æççè¬ã§ãããããã¯ãççã軜æžããå
ç«ã·ã¹ãã ãæå¶ããçã¿ãé²ãããšã«ãã£ãŠæ©èœããŸãã ãããã®è¬ã¯ãé¢ç¯ãªãŠããã忝ãå€åœ¢æ§é¢ç¯çãªã©ã®æ
¢æ§ççæ§çŸæ£ã®æ²»çã«ãã䜿çšãããŸãããŸããã¢ã¬ã«ã®ãŒãã¢ãžãœã³ç
ãªã©ã®èªå·±å
ç«çŸæ£ãç§»æ€æçµ¶åå¿ã«ã圹ç«ã¡ãŸãã ãããããããã®è¬ãé·æé䜿çšãããšã骚ç²é¬çãšåŒã°ãã骚ãããããªãå¯èœæ§ããããŸãã骚ãä¿è·ããããã«ã«ã«ã·ãŠã ãšãã¿ãã³ D ã®ãµããªã¡ã³ããæåããããšã«ã€ããŠå»åž«ã«çžè«ããŠãã ããã çã¿ã軜æžããããã®ã¹ããã€ãé¢ç¯å
泚å°ã¯ãå€åœ¢æ§è¡é¢ç¯çãŸãã¯èé¢ç¯çã®æ£è
ã«ããè¡ãããŸãããããã2022幎6æã«çºè¡šãããå€§èŠæš¡ãªç ç©¶ã§ã¯ãé¢ç¯çœ®æè¡ã®å¿
èŠæ§ãé«ãŸãå¯èœæ§ãããããšã倿ããŸããã å€è¡å°æ¿è¡æŒ¿ è¡æ¶²ãæ¿çž®ããå€è¡å°æ¿è¡æŒ¿ (PRP) ã¯ãçã¿ã䌎ãçç¶ãç·©åããæ²»çãä¿é²ããæ°ããè¡é¢ç¯æ²»çæ³ã§ãããŸããé¢ç¯çœ®ææè¡ã®å¿
èŠæ§ãé
ããå¯èœæ§ããããŸãã PRP ã¯ãè¡æ¶²ãµã³ãã«ãæ¡åããé å¿å颿©ã§å転ãããŠè¡å°æ¿ãæ®ãã®è¡çããåé¢ããããšã«ãã£ãŠäœãããŸããããã«ãããPRP ã«ã¯éåžžã®è¡æ¶²ããã 5 ïœ 10 åé«ãè¡å°æ¿æ¿åºŠãäžããããŸãã æªæã®éãè¡å°æ¿ã¯è¡æ¶²ã®ååºãå©ããæé·å åãæå·éšäœã«éã³èŸŒãã§æ²»çãæ©ãããšããéèŠãªåœ¹å²ãæãããŸãã PRP ã¯æå·çµç¹ã«çŽæ¥æ³šå°ãããçèãé±åž¯ãè
±ã®æå·ãå«ãããã€ãã®æŽåœ¢å€ç§ççç¶ã®æ²»çã«äœ¿çšã§ããŸããé¢ç¯ç;ãããŠéªšæã ããç ç©¶ã§ã¯ãã³ã«ãã³ã¹ããã€ãæ²»çã«åå¿ããªãã£ãæ
¢æ§äºåè©æ£è
29åã«ãããŠãä¿åçæ³ãšæ¯èŒããŠPRPååæ³šå°ã«ããçã¿ãšæ©èœã¹ã³ã¢ãæ¹åãããããšãããããŸãããããã«ããJournal of Arthroscope and Associated Surgeryãã«æ²èŒãããç ç©¶ã§ã¯ãPRPãšãã¢ã«ãã³é
žæ³šå°ã®äœµçšãå€åœ¢æ§è¡é¢ç¯çã®æ£è
ã«å¹æçã§ãããšå ±åããŸããã...
ã¬ãããã» ããŒãµ ãã£ã©ãŒ
人æ°ã®ãã¢ã«ãã³é
žãã£ã©ãŒã§ããããŒãµã¯ãé¡ã®èåã®å
åãæ¹åããã女æ§ãšç·æ§ã®éã§äººæ°ããããŸããæ³šå
¥ãç°¡åãªã ãã§ãªããä»ã®å€ãã®ç®èå
å¡«å€ãããå¿«é©ã§ãã ãã®ãã¢ã«ãã³é
žããŒã¹ã®ãã£ã©ãŒã¯ãåã®ãµã€ãºã倧ããããå£ã®åšãã®å°ããããããæ»ããã«ããã®ã«æé©ã§ãããããé ¬ããµã£ãããããã»ãããç·ãæ¹åããé¡ã®ããªã¥ãŒã ãåãæ»ãã®ã«ã广çã§ãã ãŽã¡ãŒãµãšã¯äœã§ããïŒ åã«ããªã¥ãŒã ãå ããŠèŒªéãã¯ã£ããããããå Žåã¯ãRevanesse Versa ãã£ã©ãŒãæé©ãªããªãŒãã¡ã³ãã§ãããã®æ³šå°å¯èœãªç®èå
å¡«å€ã¯ãã¢ã«ãã³é
žã§æ§æãããŠãããåãé¡ã®åšå²ã®å°ãããããããã®ä»ã®èåã®å
åãæ¹åããããã«äœ¿çšã§ããŸãã ãã®ãã£ã©ãŒã«å«ãŸãããã¢ã«ãã³é
žã¯ç®èã«æ°ŽåãåŒãå¯ããæãããèªç¶ãªããªã¥ãŒã ãäžããç®èã®ããã¿ãããã軜æžããŸãããŸããé¡ãæ»ããã«ããŠåœ¢ãæŽããèªç¶ã§ãããããªå€èгãå®çŸããŸãã ãŸããVersa ã¯ååéãé«ããããäœå
ã§ãããã£ãããšåè§£ãããçµæãããé·ãæç¶ããŸããããã«ã现ãã²ãŒãžã®éã䜿çšããŠæ³šå°ã§ããããã«èšèšãããŠãããThixofix æ¶æ©æè¡ãåããŠãããããæ³šå°äžã®ç²åºŠãäœããªããå§åãè§£é€ããããšéåžžã®ç¶æ
ã«æ»ããŸããããã¯æ³šå°åŸã®è
«ããæå°éã«æããã®ã«åœ¹ç«ã€ããããã£ã©ãŒæ²»çãæå€§éã«æŽ»çšããã人ã«ãšã£ãŠã¯ããè¯ãéžæã§ãã Versaã¯ãã¢ã«ãã³é
žãã£ã©ãŒã§ã ãã¢ã«ãã³é
žã¯ãæãããããªã¥ãŒã ã®ããèã«äžå¯æ¬ ãªå€©ç¶ç©è³ªã§ããæ°Žåãç®èã«çµåãããèªç¶ãªæ§é ãç¶æããã®ã«åœ¹ç«ã¡ãŸãã幎霢ãéãããšãã¢ã«ãã³é
žã®çæãé
ããªããé¡ã®ããªã¥ãŒã ã®æžå°ãã·ã¯ã®åå ãšãªããŸãã 幞ããªããšã«ãJuvedermãRestylaneãSculptraãRadiesse ãªã©ããã¢ã«ãã³é
žãå«ãããŸããŸãªç®èå
å¡«å€ããããŸãããããã®æ³šå°å¯èœãªè£œåã¯ãããããèåã®ç¹å®ã®å
åãæ²»çããããã«é
åãããŠããŸãã Versa ã¯ã2017 幎㫠FDA ã®æ¿èªãåããæ¯èŒçæ°ãããã¢ã«ãã³é
žãã£ã©ãŒã§ããç¹çްã§èªç¶ãªä»äžãããå®çŸããçæ³çãªãã£ã©ãŒã§ããå°ããªç圢ã®ãã¢ã«ãã³é
žç²åã䜿çšããŠãããããæ³šå
¥ãã¹ã ãŒãºã«ãªããä»ã®ãã¢ã«ãã³é
žãã£ã©ãŒãããèšæœ€ã 24% å°ãªããªããŸãã ããŒãµã¯å®å
šã§ã Versa ã¯ãé¡ã®ããŸããŸãªéšåã«äœ¿çšã§ããå®å
šã§å¹æçãªãã£ã©ãŒã§ãããããæ»ããã«ããåãé ¬ãé¡ã®ã©ã€ã³ã«ããªã¥ãŒã ãå ããããšãã§ããŸãã ä»ã®ãã¢ã«ãã³é
žããŒã¹ã®ç®èå
å¡«å€ãšäŒŒãŠããŸãããVersa ã®çç¶ç²åã«ããããã®ããªãŒãã¡ã³ãã¯ç¹ã«å¹æçã«èã«æº¶ã蟌ã¿ãŸãããããã®ç²åã¯ä»ã® HA ããŒã¹ã®ãã£ã©ãŒãããé·æã¡ããåŸåããããåŠçåŸã®èšæœ€ãããã»ã©å€§ãããããŸããã ãã®ãããVersa ã¯ãJuvederm...
ãããã£ã©ãŒããã5
ãããã£ã©ãŒã¯ãç®èã®åŒ±ã£ãéšåã®ããªãšåœ¢ç¶ãå埩ããçŸå®¹åŠçœ®ã®äžçš®ã§ããããã¯ãé¡ã®ç¹å®ã®é åã«å°éã®ãã£ã©ãŒã泚å
¥ããããšã«ãã£ãŠè¡ãããŸãã ãããã£ã©ãŒã«ã¯ããŸããŸãªçš®é¡ãããããããããç°ãªãç®èã®åé¡ãæ²»çããããã«èšèšãããŠããŸãããããã£ã©ãŒã®äžã«ã¯ãäž»ã«å³å¹æ§ãç®çãšããŠäœããããã®ããããŸãããé·æçãªå¹æããããããã®ããããŸãã Boyd's ãªã³ã¯ã« ãã£ã©ãŒ ã¡ã€ã¯ã¢ãã ããŒã¹ & ã¹ã ãŒã¶ãŒ èãæ»ããã«ãããªã³ã¯ã«ãã£ã©ãŒããæ¢ããªããBoyd's Wrinkle Filler Makeup Base & Smoother ããŽã£ããã®è£œåãããããŸãããã·ã¯ãåããŠãã¬ã³ãããããªããŒã®çµã¿åãããå«ãŸããŠãããæ»ããã§è¥ã
ããå€èгãå®çŸããŸãã ãã®ã·ã¯åãå€ã«ã¯ãã¢ã«ãã³é
žãå«ãŸããŠãããæ°Žåã¬ãã«ãé«ããèã®ãã¡ãŒãžã®ä¿®åŸ©ã«åœ¹ç«ã¡ãŸããæé
žåç©è³ªã¯ãèãžã®ããªãŒã©ãžã«ã«ã«ãããã¡ãŒãžã軜æžããŸãã ããã«ããã®ãªã³ã¯ã«ãã£ã©ãŒã¯ãã€ã€ã¢ã³ãããŠããŒã䜿çšããŠãããå
ãåå°ããŠã·ã¯ãé²ããŸããããã«ããããããã¯å®è³ªçã«èŠããªããªããé¡ã«çŸããã®ãé²ããŸãã ãã¬ã¹ & ãªã㌠ã¢ã³ããŒã¢ã€ ã¯ãªãŒã Terez & Honor ã¢ã³ããŒã¢ã€ ã¯ãªãŒã ã¯ãç®ã®åšãã®å°ããããããæžããã®ã«åœ¹ç«ã€ãããã£ã©ãŒã§ããããã¿ãã¯ãã軜æžããã®ã«ã圹ç«ã¡ãŸãã å®å
šã§èã«åªããåŠæ¹ã§ãé·æçã«ã¯ãããã®åå ã«ãªããŸãããã¡ã³ããã³ã¹ãæé€ãç°¡åã§ãã...
ããè¥ã ããå€èгã®ããã®ã¢ã€ãã£ã©ãŒ
ããªãã®ç®ã¯ä»ã®äººãæåã«ç®ã«ãããã®ã§ãããã¯ããããŒãã ç®ãç®ã®äžã®ããã¿ãããããããšãç²ããå°è±¡ãäžããè¿ã¥ããããå°è±¡ãäžããããšããããŸãã ã¢ã€ãã£ã©ãŒïŒããŒãã«ãã£ã©ãŒïŒã¯ãç®èã«ããªã¥ãŒã ãšåŒŸåæ§ãäžããæ³šå°å¯èœãªã²ã«ç¶ã®æº¶æ¶²ã§ãããŸããã³ã©ãŒã²ã³ã®çæãä¿é²ããé¡ã«è¥ã
ããèŒããäžããŸãã 1. ã¬ã¹ãã¬ã³Â® Restylane® ã¯ãäœå
ã«ååšãã倩ç¶å€ç³é¡ã§ãããã¢ã«ãã³é
ž (HA) ãå«ãå
å¡«å€ã§ãããã®éæãªãžã§ã«ã¯éåžžã«æãããããªãããªãã¯ã¹ãã£ãŒãæã¡ãå°ãããã·ã¯ã軜æžãã广ãéåžžã«é«ãã§ãã ãŸããåã®ã©ã€ã³ãæ»ããã«ãããã®åœ¢ã匷調ããããšã§ãåã«ããªã¥ãŒã ãå ããããšãã§ããŸãã錻ããå£è§ãŸã§ç¶ã瞊ã®ç·ã§ããã»ãããç·ã®ããæ£è
ã«é©ããŠããŸãã HA ããŒã¹ã®ç®èå
å¡«å€ã®ãã 1 ã€ã®å€§ããªå©ç¹ã¯ãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããã«ããããšã§ãããããã®è£œåã¯ã泚å°éšäœã®åšå²ã®ãããè
«ãã軜æžããã®ã«åœ¹ç«ã€ã¹ããã€ã ã¯ãªãŒã ãšçµã¿åãããŠäœ¿çšââãããããšããããããŸãã ç®ã®è¥è¿ãã« Restylane ã䜿çšãããšãçã¿ãããŠã³ã¿ã€ã ã䌎ãããšãªããã¯ãã軜æžããç®ã®äžã®ããŒã¿ã軜æžããããšãã§ããŸãããããã®é åãé€å»ãããããå€ç§çä»å
¥ã®æºåãã§ããŠããªãæ£è
ã«ãšã£ãŠãããã¯åªããä»£æ¿ææ®µã§ãã 2. ãžã¥ãããŒã ® Juvederm® ã¯ãäœå
ã«å€©ç¶ã«ååšããç©è³ªã§ãããã¢ã«ãã³é
žã§äœãããçç®å
å¡«å€ã§ããšã©ã¹ãã³ãã³ã©ãŒã²ã³ãšã®çµåãå©ããèã«å¿
é ã®æ é€çŽ ãšåŒŸåæ§ãäžããŸããããã«ãããJuvederm ã¯ãæå€§ 9 ïœ 18 ãæéæç¶ããèªç¶ãªå€èгã®çµæãç¬æã«äœãåºãããšãã§ããŸãã ãžã¥ãããŒã ãé¡ã«æ³šå°ãããšã倱ãããããªã¥ãŒã ãå埩ããç¹ã«å£ã®éšåã®å°ãããã·ã¯ãæ¹åãããŸãããŸããèã«æœ€ããäžããæ»ããã§è¥ã
ããèŒããäžããŸãã æ²»çäžã®çã¿ã軜æžããããã«ããžã¥ãããŒã 泚å°ã«ã¯å°éã®ãªãã«ã€ã³ã泚å
¥ãããŸãããã®æ²»çã¯ã»ãŒãã¹ãŠã®äººã«ãšã£ãŠå®å
šã§å¹æçã§ãã Juvederm ã¯ãåžå Žã§å
¥æå¯èœãªæãäžè¬çãªç®èå
å¡«å€ã®...
éåœã®ãã£ã©ãŒ
éåœã®ãã£ã©ãŒã¯ãé¡ãé¡ãé ¬ããããã¿ã®ããã®äžã®çèãæãããããæ³šå°å€ã§ããããªã¥ãŒã ã¢ãããšããŠãæ©èœããŸãã éåœã§ã¯ãJuvederm Ultra ã Restylane ãªã©ãããã€ãã®ãã¢ã«ãã³é
žãã£ã©ãŒãå
¥æå¯èœã§ãããã®ä»ã®äººæ°ã®ããéåœã® HA ãã£ã©ãŒã«ã¯ãã€ãã¯ãŒã«ããšã©ãŽã£ãŒãªã©ããããŸãã 1. ãªããŒã·ãã« ãã£ã©ãŒã¯ããããç·ããããåãé€ãåªããæ¹æ³ã§ããé¡ã®ããªã¥ãŒã ãåãæ»ãã®ã«ã广çã§ãã éåœã§ã¯ããŸããŸãªãã£ã©ãŒãã©ã³ãããããããããŸãããããã«ã¯èŒžå
¥ãã©ã³ããšåœå
ãã©ã³ããå«ãŸããŸãã ãã£ã©ãŒãéžæããéã«èæ
®ãã¹ãäž»ãªèŠçŽ ã® 1 ã€ã¯å®å
šæ§ã§ããäžéšã®ãã£ã©ãŒã¯ãã¢ã¬ã«ã®ãŒåå¿ãè
«ãããããåŒãèµ·ããå¯èœæ§ããããŸãã ãã 1 ã€ã®èæ
®äºé
ã¯ããã£ã©ãŒãã©ããããã®æéæç¶ãããã§ãããã£ã©ãŒã«ãã£ãŠã¯äœå¹Žã䜿çšã§ãããã®ããããŸãã éåœè£œãã£ã©ãŒã¯éåžžå®å
šã§ãããããããã®ãã£ã©ãŒã«é¢é£ããå
·äœçãªãªã¹ã¯ã«ã€ããŠå»åž«ã«çžè«ããããšãéèŠã§ããããªãã®èã¿ã€ããçŸçç®æšã«æé©ãªãã£ã©ãŒãéžæãããæäŒããããããŸãã 2. é«å質 éåœã§ç®èå
å¡«å€ãå
¥æãããå Žåã¯ãé«å質ã®è£œåãéžæããå¿
èŠããããŸããããŸããŸãªãã©ã³ãããããèªåã®ããŒãºã«åã£ããã®ãéžæããå¿
èŠããããŸãã ããªãã®ç®æšãåãçŸããããããã»ãããç·ãæ¹åãããããããšã§ããå Žåã¯ããããã PMMA ãã€ã¯ãã¹ãã£ã¢ãšãã¢ã«ãã³é
žãæ¢ããããªãã§ãããããããã¯ãã¹ãŠFDAã®æ¿èªãåããŠãããããŸãæ©èœããŸãã éåœè£œãã£ã©ãŒã¯ãã»ãããç·ãå°ããã軜æžãããå Žåãé ¬ãåã匷調ãããå Žåãæè¡ãªãã§éŒ»ãé«ãããã®ã«é©ããéžæè¢ã§ãããããã®ãã£ã©ãŒã¯æåœ¢ãç°¡åã§ãåªããããªã¥ãŒã ãæã¡ãæé· 18 ãææç¶ããŸãã 3. æé ãªäŸ¡æ Œ...
é¡ã®ããã¿ããžã§ãŒãã£ã©ãŒã§ä¿®æ£ãã
é¡ã®ããã¿ããããæè¡ããã«æ²»ãããå Žåã¯ãé¡å
å¡«å€ã圹ã«ç«ã¡ãŸãããã®æ²»çã§ã¯ãç®èå
å¡«å€ã䜿çšããŠé¡ã®åœ¢ç¶ã埮åŠã«å€åãããé¡å
šäœã®å€èгã«é¡èãªéããçã¿åºãããšãã§ããŸãã ã«ãŠã³ã»ãªã³ã°äžã«ãçç·Žããæ³šå°åšãããªãã®ããŒãºãšç®æšãè©äŸ¡ããŸãããã®åŸãã客æ§åºæã®ç¶æ³ã«æé©ãªåŠæ¹ãæšå¥šããŸãã åãäžãã£ãé¡ å¹Žéœ¢ãéããã«ã€ããŠãé¡ã®ããã¿ã¯ããäžè¬çã«ãªããŸããã幞ããªããšã«ãé¡ã®ããã¿ã軜æžãŸãã¯äºé²ããããã«å©çšã§ããæ²»çãªãã·ã§ã³ãæ°å€ããããŸãã é¡ã®ããã¿ã«ã¯ãäœéã®å¢æžãæ¥å
ãžã®æé²ãå«ç
ãªã©ãããŸããŸãªèŠå ãèããããŸããããããããã®çºçãé²ãæã广çãªæ¹æ³ã¯ãå«ç
ãæ¥å
ã«ãããã¡ãŒãžãé¿ããããšã§ãã é¡ã®ããã¿ã®ããäžã€ã®åå ã¯ãäžé©åãªã¹ãã³ã±ã¢ç¿æ
£ã§ããæ é€äŸ¡ã®é«ãã¹ãã³ã±ã¢è£œåã宿çã«äœ¿çšããæé
žåç©è³ªãæççç©è³ªããã¢ã«ãã³é
žãã³ã©ãŒã²ã³ãè±å¯ãªé£äºãæåãããšãèã®åŒŸåæ§ãåäžããé¡ã®ããã¿ãé²ãããšãã§ããŸãã ãããã®å¯Ÿçã«å ããŠãé¡ã®ããã¿ã軜æžããããã«äœ¿çšã§ããå€ç§çåŠçœ®ããããŸãããããã¯ããã¯ãªãããšåŒã°ããå€ãã®å ŽåçŸå®¹å€ç§å°éå»ã«ãã£ãŠè¡ãããŸããéŠã®åŽé¢ã®åšããåéããŠãèèªã®äœçœ®ã倿ŽããçèãåŒãç· ããé¡ã®èŒªéãæŽããããšãå«ãŸããŸãããããã®æè¡ã¯é¡ã®ç®èãäœå¹Žãåãé€ãã®ã«éåžžã«å¹æçã§ãããé倧ãªãªã¹ã¯ããããå䜵çãåŒãèµ·ããå¯èœæ§ããããŸãã é¡ãã£ã©ãŒ ãã³ãã£ã©ãŒã¯ãããã¯ã£ãããšãã圫å»çãªé¡ã®ã©ã€ã³ãå®çŸããããšé¡ããããã幎霢ã®å¥³æ§ãšç·æ§ã«äººæ°ã®æ²»çæ³ã§ãããŸããããªã¥ãŒã ãå ããŠé察称ãªé¡ã®åœ¢ãæ¹åããããé床ã«éãã£ããè§åŒµã£ãé¡ã®ã©ã€ã³ãåããããããããã«ã䜿çšãããŸãã ãã£ããããããã¯çŸããé¡ã®éµã§ããããããããã匱ããªãã®ã¯ãå 霢ãäœéå¢å ããŸãã¯ãã®éšåã®ç®èã®ããã¿ãåŒãèµ·ãããã®ä»ã®èŠå ã«ãã£ãŠåŒãèµ·ããããå¯èœæ§ããããŸãã 幞ããªããšã«ããžã§ãŒã«ãã£ã©ãŒã§ä¿®æ£ã§ããŸãããã®éå€ç§çæè¡ã«ã¯ãé¡ãšäžé¡ã®èŒªéã«ãã¢ã«ãã³é
žã²ã«ã泚å
¥ããããšãå«ãŸããŠãããããã«ããçµç¹ãæã¡äžããŠå®¹ç©ãå€ããé¡ã®ããã¿ã®å€èŠ³ãæ¹åããããšãã§ããŸãã é¡ãã£ã©ãŒæ²»çãåããåã«ãæ
åœè
ãããªãã®é¡ãæ€æ»ããç®æšã«ã€ããŠè©±ãåããŸããããã¯ãããªãã«ãšã£ãŠæé©ãªãã£ã©ãŒã®çš®é¡ãšéãæ³šå
¥ã®æ·±ããšäœçœ®ã決å®ããã®ã«åœ¹ç«ã¡ãŸãã é©åºŠãªé¡ 軜床ã®é¡ã®å Žåã¯ãé¡å
å¡«æ²»çãæ€èšãããšããã§ããããããã¯ãé¡ã®ã©ã€ã³ãæ»ããã«ããŠèŒªéãæŽãããã圫ãã®æ·±ããããã£ãŒã«ãå®çŸã§ãããããç·æ§ãšå¥³æ§ã®äž¡æ¹ã«äººæ°ã®ãªãã·ã§ã³ã§ãã ãã®æ²»çã¯ãå»åŠçã«éçºãããæº¶æ¶²ã现ãéã§ç®äžã«æ³šå°ããããšã§è¡ãããŸããé¡ã埮åŠã«æ»ããã«ãã茪éãæŽãã調åãæŽããé¡ç«ã¡ãéç«ãããã®ã«åœ¹ç«ã¡ãŸãã ãããã¯ãé¡ã®å€èŠ³ãæ¹åããããã«ãSculptra(tm) ãŸãã¯ã¹ã¬ãã ãªããã䜿çšããããšãã§ããŸãããŸãããã®éšåã®ã³ã©ãŒã²ã³ãåºæ¿ããã®ã«ã圹ç«ã€ãããäžçšåºŠã®é¡ãæ²»çããããã®åªãã代æ¿åãšãªããŸãã é¡ã¯èåã®æãäžè¬çãªå
åã® 1 ã€ã§ãããæ¥å
ã«ãããã¡ãŒãžãå«ç
ãéºäŒãé£äºãçæŽ»ç¿æ
£ã«ãã£ãŠåŒãèµ·ããããå¯èœæ§ããããŸããããããé²ãæåã®æ¹æ³ã¯ãå¥åº·çãªé£äºãç¶æãã宿çã«éåããæ¯æ¥ã®æ¥çŒãæ¢ãã§æ¥å
ããèãå®ãããšã§ãã ã¢ãã¬ãŒããã©ã¹ãžã§ãŒã« äžçšåºŠã®ãã©ã¹é¡ã¯è»œåºŠã®é¡ãããé¡èã§ãããé¡å
å¡«å€ã§æ²»çã§ããŸãïŒãã®æ²»çæ³ã«ã€ããŠã®è©³çްã¯ãç§ã®èšäºã§è©³ãã説æããŠããŸãïŒãéåžžãæ£è
ã¯åºæ¬çã« 4 ïœ 8 æ¬ã®æ³šå°åšãå¿
èŠãšããããã 2 ïœ 9...
